HOME >> BIOLOGY >> NEWS
Open Access Initiative from Oxford Journals

Oxford University Press (OUP) is initiating an Open Access experiment with one of its flagship journals, Nucleic Acids Research (NAR), recently listed by ISI as one of the top ten 'hottest' journals of the decade in biology and biochemistry . This initiative is in response to calls from the academic community to make research freely available online without the barrier of a subscription to access.

NAR will adopt an author-funded publishing model for a key section of the journal (the annual Database Issue published in January 2004), with these papers being freely available online from the moment they are published. If successful, the rest of the journal would gradually move to an open access model over a transitional period of 4-5 years, at which point all research published in NAR would be funded in such a way.

"As a University Press we believe in making research as globally accessible as possible", commented Martin Richardson, Director of OUP Journals Division, "but very few well-established journals have made a move to Open Access. NAR is a highly respected international journal, and as such we must ensure that its quality is maintained through continuing to cover the costs that the refereeing process and online publishing incur. Our proposal is to cover these costs through a combination of author charges and subscription revenues, with author charges gradually increasing over time until the model is self-funding. We believe that the adoption of a transitional approach is of vital importance for both authors and readers. Unless funding conventions change, and all authors have access to sufficient financial resources to pay for the full publication costs of their research, it is unlikely that Open Access publishing would be widely adopted by well-established journals."

OUP hopes that its initiative will help lead the way in exploring alternatives to the subscription model that will make research literature as widely accessible as possib
'"/>

Contact: Rachel Goode
rachel.goode@oupjournals.org
44-795-749-1505
Oxford University Press
7-Aug-2003


Page: 1 2

Related biology news :

1. BioMed Central to consult funders and librarians over Open Access payment model
2. Access to DNA secrets yields better understanding of genes, possible tool for disease diagnosis
3. Open Access journals proven to compete on quality
4. OUP launch a new Open Access Journal on Complementary and Alternative Medicine
5. BioMed Central explodes Open Access myths
6. Access to healthy foods limited in poor neighborhoods
7. Sick Kids Improves Access To Global Genome Database
8. Keck Futures Initiative announces grant recipients
9. GenVec, U.S. NMRC, and PATHs Malaria Vaccine Initiative partner to expand malaria vaccine efforts
10. Hydrogen Initiative report from American Physical Society panel released
11. Initiative launched for computer science

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2019)... ... March 29, 2019 , ... GenCure has selected ... cell therapy facility. The new facility, which will anchor the VelocityTX innovation center ... the art manufacturing capabilities to support clinical cell therapy trials. GenCure is a ...
(Date:3/25/2019)... ... March 25, 2019 , ... Ambry Genetics ... genetic testing, today announced a new laboratory services agreement with Clovis Oncology Inc., ... Through this laboratory services agreement, Ambry Genetics and Clovis Oncology seek to ...
(Date:3/19/2019)... , ... March 19, 2019 , ... ... EMulate Therapeutics, Inc. The name change is effective immediately for the ... other serious diseases. , In making the announcement, Chris Rivera, Chief Executive ...
Breaking Biology News(10 mins):
(Date:4/9/2019)... ... 09, 2019 , ... The American Society of Gene & Cell Therapy ... including a new addition to the presidential line of succession, at the 22nd ... Society's leadership team for a three-year term (2019-2021). , All five incoming members of ...
(Date:4/8/2019)... (PRWEB) , ... April 09, 2019 , ... ... disease, the innovative non-profit research center Chan Zuckerberg Biohub (CZ Biohub) has chosen ... of antibody repertoires is part of CZ Biohub’s efforts to establish new approaches ...
(Date:3/29/2019)... ... March 28, 2019 , ... Specific Diagnostics announced ... proceeded with a second stage of funding for Specific’s Reveal™ rapid antibiotic susceptibility ... top of the $1.7 million already awarded by CARB-X. The additional $1.7M will ...
(Date:3/27/2019)... ... 27, 2019 , ... Lachman is sponsoring the event on April 1-4, where ... Ireland. The executive team on site will be available to discuss strategies and tactics ... agenda this year. , Executives from Lachman participating at this year’s conference include Fran ...
Breaking Biology Technology:
Cached News: